Early and Sustained Improvements in Sense of Smell with Tezepelumab Treatment in Patients with CRSwNP (WAYPOINT)
New clinical trial data reveals that tezepelumab, a targeted biologic therapy, demonstrates significant and lasting improvements in the sense of smell for adults suffering…
